Melanoma brain metastases: is it time to eliminate radiotherapy?

ConclusionsFor melanoma patients requiring WBRT, immunotherapy alone may be reasonable in asymptomatic patients. For those eligible for SRS, combination therapy may provide better outcomes. Results of ongoing prospective studies will help provide guidance regarding the use of radioimmunotherapy in this population.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research